Tag Archives: inovio pharmaceuticals stock

Bill Gates co-founded Microsoft in 1975 with Paul Allen and was CEO until 2000. Gates was director of the board at Microsoft until 2014. But now he is leaving the board to focus on philanthropy.Microsoft said yesterday that its co-founder Bill Gates is stepping down from its board of directors. Gates co-founded Microsoft in 1975 and was acting as the chairman of the board until 2014. Back in 2008 he stepped back from day-to-day operations.Gates explained this unexpected move with the...

Inovio stock has been swung significantly in the last 24 hours after rising on news of a new grant and plunging on news of its poor Q4 report.The continuous spread of the coronavirus COVID-19 strain has directly placed a large spotlight on biotech companies and their stock. Because most of them are scrambling to find some treatment or vaccine for the virus, they have seen sharp spikes in value like never before experienced. For Inovio Pharmaceuticals (NASDAQ: INO) stock, several market...

Citron Research warned investors that Ino stock would fall back to $2 and called for the Securities and Exchange Commission to investigate Inovio and suspend trading of its stock.Pharma company Inovio Pharmaceuticals Inc (NASDAQ: INO) had pretty volatile trading session yesterday. It started by growing 10.7% but in just a few minutes, the biotech quickly started to fall. INO stock finished its trading session with 42.01% in the red and with a price of $5.7.But, let’s start from the beginning....

Inovio (INO) stock has now erased some of its YTD gains after Citron Research suggested the company was grandstanding. Citron’s analysts now put INO at $2.Several factors affect the volatility of financial markets all over the world. In recent times, it’s been the coronavirus outbreak. The uncertainty and fear have caused a general plunge in the markets. However, some stocks – specifically biotech companies – rode on the epidemic for a time, and increased in value. Inovio Pharmaceuticals Inc...

Dow Jones has lost over 1,880 points due to a row of factors including Saudi’s oil price slash as well as the coronavirus that is quickly spreading. More bleeding is expected.All over the world, markets have been feeling terrible effects of the coronavirus COVID-19 outbreak. In recent times, the epidemic has caused stocks to plunge considerably, with a lot of companies seriously bleeding. Projections for the coronavirus have been quite pessimistic with forecasts that things will get worse....

Inovio(INO) stock is enjoying the rally as it put on almost 8% weight days after it announced that it will be speeding up plans for its coronavirus (COVID-19) vaccine.There are a few biotech companies currently working on treating the new coronavirus COVID-19 strain. For these companies right now, nothing is more important than giving the world a solution to either treat or prevent new cases of the virus, via a vaccine. While there is considerable progress being made by these firms, Inovio...

Inovio plans to start a clinical trial of its coronavirus vaccine in the U.S. next month with the thought to expand to China and South Korea shortly thereafter.Inovio Pharmaceuticals Inc (NASDAQ: INO) is up over 18% in the premarket. Now its price is $8.80. But on Tuesday its results were even more impressive. INO stock gained practically 70%, reaching the level of $7.45. It happened after Inovio announced it has been speeding up the timeline for the development of a vaccine to treat the...

As major biotech companies try to create a proper coronavirus vaccine, the following stocks just might be strong enough to hedge against the current financial plunge.The coronavirus epidemic isn’t letting down as many people hope it would. Instead, the number of confirmed cases as well as the mortality rate, are on a steady rise. The number of countries affected by the virus is also increasing steadily with many more countries confirming new cases of infection. The situation is worrisome to...

While tech shares are suffering drops, coronavirus stocks are soaring, The pharma companies are actively working on the development of a new vaccine.Lately, we have been reporting a lot about tech companies suffering significant drops in stocks amid spreading coronavirus concerns. Its high time to have a look at those market players who are benefiting in the volatile conditions. Under the circumstances given, the only winners are so-called coronavirus stocks. Haven stocks and health care...